Alerts
4283 total results. Page 123 of 172.
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
Timothy J. Feighery, Lee M. Caplan
Monthly Wrap: News, insights and analysis from Arent Fox's International Arbitration team.
Colorado’s new consumer data protection law, the Protections for Consumer Data Privacy Act, took effect September 1 and companies now have another set of requirements to comply with for their data privacy compliance.
Tracy L. McLaughlin
Individuals with disabilities and their families have many options to set aside funds without jeopardizing eligibility for means-tested government benefits.
Anthony V. Lupo, Matthew R. Mills, Megan A. Rzonca
Retailers across the country are paying close attention to a series of legal battles over state laws that prohibit merchants from charging an extra fee to consumers who pay by credit card.
Birgit Matthiesen, David R. Hamill
If the turbulence of 2018 caused business executives grief, the year ahead is unlikely to provide much relief. Foremost is the United States-Mexico-Canada Agreement (USMCA). If most political pundits are correct, the three governments will likely be able to ratify the USMCA in time to be in full fo
Bradford C. Frese
On October 11, the United States Patent and Trademark Office published a new final rule altering the claim construction standard applied in inter partes review, post grant review, and covered business method review proceedings.
Stephanie Trunk
The Department of Health and Human Services (HHS) has issued a proposed rule (PR) which would require any television advertisement for a drug or biological covered by Medicare or Medicaid to include a disclosure of the product’s “current list price” for a “typical” thirty day supply.
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
Nancy A. Noonan
On October 17, 2018, Canada celebrated Legalization Day – an event marking the end of a prohibition against recreational cannabis use.
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
Stephanie Trunk
President Trump is expected to sign into law a bill which will – among other things – expand the scope of the Open Payments reporting requirements mandated by Section 6002 of the Patient Protection and Affordable Care Act (often referred to as the Sunshine Act).
Robert G. Edwards, Ph.D.
Efforts to update FDA’s personal care products regulations continue as Rep. Jan Schakowsky (D-IL) recently introduced H.R. 6903, the “Safe Cosmetics and Personal Care Products Act of 2018.”
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
In December 2017, Congress passed major changes to the tax laws.
Stephanie Trunk
On September 28, 2018, the Pharmaceutical Research and Manufacturers of America (PhRMA) filed an amended complaint to revive its lawsuit seeking to block implementation and enforcement of California’s drug price transparency law.
Darrell S. Gay
On October 1, 2018, the New York State Department of Labor announced its final regulations to prevent workplace harassment.
D. Jacques Smith, Randall A. Brater, Michael F. Dearington, Rebecca W. Foreman, Nadia Patel
Headlines that Matter for Companies and Executives in Regulated Industries
John Gurley, David R. Hamill, Birgit Matthiesen
In the last hour of the last day of last month, with 30 minutes to spare, US Trade Representative Lighthizer met the US self-imposed deadline and formally sent to Congress the agreed-upon text of a US-Mexico-Canada Agreement, or USMCA.
Timothy J. Feighery, Ucheora Onwuamaegbu*
September Arbitration Wrap: News, Knowledge, and Insight
Emily M. Leongini
Last week, the Drug Enforcement Agency (DEA) published in the Federal Register its Final Order placing FDA-approved cannabidiol drug products (CBD) containing no more than 0.1 percent tetrahydrocannabinols in schedule V of the Controlled Substances Act.
Nancy A. Noonan
US Customs and Border Protection’s Executive Assistant Commissioner of Field Operations, Todd Owen, recently spoke with Politico and confirmed that CBP will continue to apply long-standing US federal laws and regulations that treat marijuana as a banned substance at the US border.
Anthony V. Lupo
Starting on January 1, 2020, fashion and retail companies from around the world will need to comply with the strongest online privacy law in the United States, the California Consumer Privacy Act of 2018.
David Llorente
The Trump Administration recently announced several major decisions, including: finalizing the List 3 products subject to additional duties and revealing its implementation schedule.
Stephanie Trunk
On September 11, 2018, hospital advocacy groups and three individual hospitals filed a complaint in the United States District Court for the District of Columbia.